Salt-inducible kinase 3 signaling is important for the gluconeogenic programs in mouse hepatocytes

Journal of Biological Chemistry

Volumn 290, Issue 29, 2015, Pages 17879-17893

  Itoh, Yumi ^a   Sanosaka, Masato ^a   Fuchino, Hiroyuki ^b   Yahara, Yasuhito ^c   Kumagai, Ayako ^a   Takemoto, Daisaku ^a,d   Kagawa, Mai ^a   Doi, Junko ^e   Ohta, Miho ^f   Tsumaki, Noriyuki ^c   Kawahara, Nobuo ^b   Takemori, Hiroshi ^a  

^a NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^b Tsukuba Division   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d KANSAI UNIVERSITY   (Japan)

^e SENRI KINRAN UNIVERSITY   (Japan)

^f Soai University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GENE EXPRESSION;

GLUCONEOGENESIS; GLUCONEOGENIC GENES; HEPATOCYTES;

ENZYMES;

CELL PROTEIN; CRTC2 PROTEIN; FORSKOLIN; PHKG2 PROTEIN; PHOSPHOTRANSFERASE; SALT INDUCIBLE KINASE 1; SALT INDUCIBLE KINASE 2; SALT INDUCIBLE KINASE 3; UNCLASSIFIED DRUG; CRTC2 PROTEIN, MOUSE; GLUCOSE; INDAN DERIVATIVE; PROTEIN SERINE THREONINE KINASE; PTEROSIN B; SIK3 PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INACTIVATION; GENE EXPRESSION; GLUCONEOGENESIS; GLYCOGEN ANALYSIS; HEPATOMA CELL; INTRACELLULAR SIGNALING; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SCREENING TEST; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CHEMISTRY; DRUG EFFECTS; FEMALE; GENE INACTIVATION; GENETICS; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; CELLS, CULTURED; FEMALE; GENE KNOCKOUT TECHNIQUES; GLUCONEOGENESIS; GLUCOSE; HEPATOCYTES; INDANS; MICE; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84937501227     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.640821     Document Type: Article

References (54)

1. Takemori, H., and Okamoto, M. (2008) Regulation of CREB-mediated gene expression by salt inducible kinase. J. Steroid Biochem. Mol. Biol. 108, 287-291
2. Wang, Z., Takemori, H., Halder, S. K., Nonaka, Y., and Okamoto, M. (1999) Cloning of a novel kinase (SIK) of the SNF1/AMPK family from high salt diet-treated rat adrenal. FEBS Lett. 453, 135-139
3. Horike, N., Takemori, H., Katoh, Y., Doi, J., Min, L., Asano, T., Sun, X. J., Yamamoto, H., Kasayama, S., Muraoka, M., Nonaka, Y., and Okamoto, M. (2003) Adipose-specific expression, phosphorylation of Ser794 in insulin receptor substrate-1, and activation in diabetic animals of salt-inducible kinase-2. J. Biol. Chem. 278, 18440-18447
4. Lizcano, J. M., Göransson, O., Toth, R., Deak, M., Morrice, N. A., Boudeau, J., Hawley, S. A., Udd, L., Mäkelä, T. P., Hardie, D. G., and Alessi, D. R. (2004) LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J. 23, 833-843
5. Screaton, R. A., Conkright, M. D., Katoh, Y., Best, J. L., Canettieri, G., Jeffries, S., Guzman, E., Niessen, S., Yates, J. R., 3rd, Takemori, H., Okamoto, M., and Montminy, M. (2004) The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Cell 119, 61-74
6. Berdeaux, R., Goebel, N., Banaszynski, L., Takemori, H., Wandless, T., Shelton, G. D., and Montminy, M. (2007) SIK1 is a class II HDAC kinase that promotes survival of skeletal myocytes. Nat. Med. 13, 597-603
7. Katoh, Y., Takemori, H., Min, L., Muraoka, M., Doi, J., Horike, N., and Okamoto, M. (2004) Salt-inducible kinase-1 represses cAMP response element-binding protein activity both in the nucleus and in the cytoplasm. Eur. J. Biochem. 271, 4307-4319
8. Doi, J., Takemori, H., Lin, X.-Z., Horike, N., Katoh, Y., and Okamoto, M. (2002) Salt-inducible kinase represses PKA-mediated activation of human cholesterol side chain cleavage cytochrome promoter through the CREB basic leucine zipper domain. J. Biol. Chem. 277, 15629-15637
9. Takemori, H., Katoh, Y., Horike, N., Doi, J., and Okamoto, M. (2002) ACTH-induced nucleocytoplasmic translocation of salt-inducible kinase. Implication in the protein kinase A-activated gene transcription in mouse adrenocortical tumor cells. J. Biol. Chem. 277, 42334-42343
10. McKinsey, T. A., Zhang, C. L., Lu, J., and Olson, E. N. (2000) Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408, 106-111
11. Koo, S. H., Flechner, L., Qi, L., Zhang, X., Screaton, R. A., Jeffries, S., Hedrick, S., Xu, W., Boussouar, F., Brindle, P., Takemori, H., and Montminy, M. (2005) The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 437, 1109-1111
12. Imai, E., Miner, J. N., Mitchell, J. A., Yamamoto, K. R., and Granner, D. K. (1993) Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids. J. Biol. Chem. 268, 5353-5356
13. Bertorello, A. M., Pires, N. M., Igreja, B., Pinho, M. J., Vorkapic, E., Wagsater, D., Wikstrom, J., Behrendt, M., Hamsten, A., Eriksson, P., Soaresda-Silva, P., and Brion, L. (2015) Increased arterial blood pressure and vascular remodeling in mice lacking salt-inducible kinase 1 (SIK1). Circ. Res. 116, 642-652
14. Muraoka, M., Fukushima, A., Viengchareun, S., Lombès, M., Kishi, F., Miyauchi, A., Kanematsu, M., Doi, J., Kajimura, J., Nakai, R., Uebi, T., Okamoto, M., and Takemori, H. (2009) Involvement of SIK2/TORC2 signaling cascade in the regulation of insulin-induced PGC-1alpha and UCP-1 gene expression in brown adipocytes. Am. J. Physiol. Endocrinol. Metab. 296, E1430-E1439
15. Horike, N., Kumagai, A., Shimono, Y., Onishi, T., Itoh, Y., Sasaki, T., Kitagawa, K., Hatano, O., Takagi, H., Susumu, T., Teraoka, H., Kusano, K., Nagaoka, Y., Kawahara, H., and Takemori, H. (2010) Downregulation of SIK2 expression promotes the melanogenic program in mice. Pigment Cell Melanoma Res. 23, 809-819
16. Park, J., Yoon, Y. S., Han, H. S., Kim, Y. H., Ogawa, Y., Park, K. G., Lee, C. H., Kim, S. T., and Koo, S. H. (2014) SIK2 is critical in the regulation of lipid homeostasis and adipogenesis in vivo. Diabetes 63, 3659-3673
17. Sakamaki, J., Fu, A., Reeks, C., Baird, S., Depatie, C., Al Azzabi, M., Bardeesy, N., Gingras, A. C., Yee, S. P., and Screaton, R. A. (2014) Role of the SIK2-p35-PJA2 complex in pancreatic beta-cell functional compensation. Nat. Cell Biol. 16, 234-244
18. Uebi, T., Itoh, Y., Hatano, O., Kumagai, A., Sanosaka, M., Sasaki, T., Sasagawa, S., Doi, J., Tatsumi, K., Mitamura, K., Morii, E., Aozasa, K., Kawamura, T., Okumura, M., Nakae, J., Takikawa, H., Fukusato, T., Koura, M., Nish, M., Hamsten, A., Silveira, A., Bertorello, A. M., Kitagawa, K., Nagaoka, Y., Kawahara, H., Tomonaga, T., Naka, T., Ikegawa, S., Tsumaki, N., Matsuda, J., and Takemori, H. (2012) Involvement of SIK3 in glucose and lipid homeostasis in mice. PLoS One 7, e37803
19. Sasagawa, S., Takemori, H., Uebi, T., Ikegami, D., Hiramatsu, K., Ikegawa, S., Yoshikawa, H., and Tsumaki, N. (2012) SIK3 is essential for chondrocyte hypertrophy during skeletal development in mice. Development 139, 1153-1163
20. Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S. H., Bardeesy, N., Depinho, R. A., Montminy, M., and Cantley, L. C. (2005) The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310, 1642-1646
21. Viollet, B., Athea, Y., Mounier, R., Guigas, B., Zarrinpashneh, E., Horman, S., Lantier, L., Hebrard, S., Devin-Leclerc, J., Beauloye, C., Foretz, M., Andreelli, F., Ventura-Clapier, R., and Bertrand, L. (2009) AMPK: Lessons from transgenic and knockout animals. Front. Biosci. (Landmark Ed) 14, 19-44
22. Foretz, M., Hébrard, S., Leclerc, J., Zarrinpashneh, E., Soty, M., Mithieux, G., Sakamoto, K., Andreelli, F., and Viollet, B. (2010) Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J. Clin. Invest. 120, 2355-2369
23. Patel, K., Foretz, M., Marion, A., Campbell, D. G., Gourlay, R., Boudaba, N., Tournier, E., Titchenell, P., Peggie, M., Deak, M., Wan, M., Kaestner, K. H., Göransson, O., Viollet, B., Gray, N. S., Birnbaum, M. J., Sutherland, C., and Sakamoto, K. (2014) The LKB1-salt-inducible kinase pathway functions as a key gluconeogenic suppressor in the liver. Nat. Commun. 5, 4535
24. Kumagai, A., Horike, N., Satoh, Y., Uebi, T., Sasaki, T., Itoh, Y., Hirata, Y., Uchio-Yamada, K., Kitagawa, K., Uesato, S., Kawahara, H., Takemori, H., and Nagaoka, Y. (2011) A potent inhibitor of SIK2, 3,3′,7-trihydroxy-4′- methoxyflavon (4′-O-methylfisetin), promotes melanogenesis in B16F10 melanoma cells. PLoS One 6, e26148
25. Ratnoglik, S. L., Aoki, C., Sudarmono, P., Komoto, M., Deng, L., Shoji, I., Fuchino, H., Kawahara, N., and Hotta, H. (2014) Antiviral activity of extracts from Morinda citrifolia leaves and chlorophyll catabolites, pheophorbide a and pyropheophorbide a, against hepatitis C virus. Microbiol. Immunol. 58, 188-194
26. Takemori, H., Katoh Hashimoto, Y., Nakae, J., Olson, E. N., and Okamoto, M. (2009) Inactivation of HDAC5 by SIK1 in AICAR-treated C2C12 myoblasts. Endocr. J. 56, 121-130
27. Katoh, Y., Takemori, H., Lin, X. Z., Tamura, M., Muraoka, M., Satoh, T., Tsuchiya, Y., Min, L., Doi, J., Miyauchi, A., Witters, L. A., Nakamura, H., and Okamoto, M. (2006) Silencing the constitutive active transcription factor CREB by the LKB1-SIK signaling cascade. FEBS J. 273, 2730-2748
28. Hashimoto, Y. K., Satoh, T., Okamoto, M., and Takemori, H. (2008) Importance of autophosphorylation at Ser186 in the A-loop of salt inducible kinase 1 for its sustained kinase activity. J. Cell Biochem. 104, 1724-1739
29. Walkinshaw, D. R., Weist, R., Kim, G. W., You, L., Xiao, L., Nie, J., Li, C. S., Zhao, S., Xu, M., and Yang, X. J. (2013) The tumor suppressor kinase LKB1 activates the downstream kinases SIK2 and SIK3 to stimulate nuclear export of class IIa histone deacetylases. J. Biol. Chem. 288, 9345-9362
30. Clark, K., MacKenzie, K. F., Petkevicius, K., Kristariyanto, Y., Zhang, J., Choi, H. G., Peggie, M., Plater, L., Pedrioli, P. G., McIver, E., Gray, N. S., Arthur, J. S., and Cohen, P. (2012) Phosphorylation of CRTC3 by the salt-inducible kinases controls the interconversion of classically activated and regulatory macrophages. Proc. Natl. Acad. Sci. U.S.A. 109, 16986-16991
31. Sasaki, T., Takemori, H., Yagita, Y., Terasaki, Y., Uebi, T., Horike, N., Takagi, H., Susumu, T., Teraoka, H., Kusano, K., Hatano, O., Oyama, N., Sugiyama, Y., Sakoda, S., and Kitagawa, K. (2011) SIK2 is a key regulator for neuronal survival after ischemia via TORC1-CREB. Neuron 69, 106-119
32. Uebi, T., Tamura, M., Horike, N., Hashimoto, Y. K., and Takemori, H. (2010) Phosphorylation of the CREB-specific coactivator TORC2 at Ser(307) regulates its intracellular localization in COS-7 cells and in the mouse liver. Am. J. Physiol. Endocrinol. Metab. 299, E413-E425
33. Zhang, S., Hulver, M. W., McMillan, R. P., Cline, M. A., and Gilbert, E. R. (2014) The pivotal role of pyruvate dehydrogenase kinases in metabolic flexibility. Nutr. Metab. (Lond.) 11, 10
34. Hardie, D. G. (2014) AMPK-sensing energy while talking to other signaling pathways. Cell Metab. 20, 939-952
35. Gan, R. Y., and Li, H. B. (2014) Recent progress on liver kinase B1 (LKB1): expression, regulation, downstream signaling and cancer suppressive function. Int. J. Mol. Sci. 15, 16698-16718
36. Guigas, B., Bertrand, L., Taleux, N., Foretz, M., Wiernsperger, N., Vertommen, D., Andreelli, F., Viollet, B., and Hue, L. (2006) 5-Aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation. Diabetes 55, 865-874
37. Hurov, J. B., Huang, M., White, L. S., Lennerz, J., Choi, C. S., Cho, Y. R., Kim, H. J., Prior, J. L., Piwnica-Worms, D., Cantley, L. C., Kim, J. K., Shulman, G. I., and Piwnica-Worms, H. (2007) Loss of the Par-1b/MARK2 polarity kinase leads to increased metabolic rate, decreased adiposity, and insulin hypersensitivity in vivo. Proc. Natl. Acad. Sci. U.S.A. 104, 5680-5685
38. Sun, C., Tian, L., Nie, J., Zhang, H., Han, X., and Shi, Y. (2012) Inactivation of MARK4, an AMP-activated protein kinase (AMPK)-related kinase, leads to insulin hypersensitivity and resistance to diet-induced obesity. J. Biol. Chem. 287, 38305-38315
39. Jansson, D., Ng, A. C., Fu, A., Depatie, C., Al Azzabi, M., and Screaton, R. A. (2008) Glucose controls CREB activity in islet cells via regulated phosphorylation of TORC2. Proc. Natl. Acad. Sci. U.S.A. 105, 10161-10166
40. Miller, R. A., Chu, Q., Le Lay, J., Scherer, P. E., Ahima, R. S., Kaestner, K. H., Foretz, M., Viollet, B., and Birnbaum, M. J. (2011) Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling. J. Clin. Invest. 121, 2518-2528
41. Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., Musi, N., Hirshman, M. F., Goodyear, L. J., and Moller, D. E. (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167-1174
42. Sullivan, J. E., Brocklehurst, K. J., Marley, A. E., Carey, F., Carling, D., and Beri, R. K. (1994) Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinase. FEBS Lett. 353, 33-36
43. Blattmann, P., Schuberth, C., Pepperkok, R., and Runz, H. (2013) RNAibased functional profiling of loci from blood lipid genome-wide association studies identifies genes with cholesterol-regulatory function. PLoS Genet. 9, e1003338
44. Hanks, S. K. (1987) Homology probing: identification of cDNA clones encoding members of the protein-serine kinase family. Proc. Natl. Acad. Sci. U.S.A. 84, 388-392
45. Chan, K. F., Hurst, M. O., and Graves, D. J. (1982) Phosphorylase kinase specificity. A comparative study with cAMP-dependent protein kinase on synthetic peptides and peptide analogs of glycogen synthase and phosphorylase. J. Biol. Chem. 257, 3655-3659
46. Chrisman, T. D., and Exton, J. H. (1980) Activation of endogenous phosphorylase kinase in liver glycogen pellet by cAMP-dependent protein kinase. J. Biol. Chem. 255, 3270-3273
47. Maichele, A. J., Burwinkel, B., Maire, I., Søvik, O., and Kilimann, M. W. (1996) Mutations in the testis/liver isoform of the phosphorylase kinase gamma subunit (PHKG2) cause autosomal liver glycogenosis in the gsd rat and in humans. Nat. Genet. 14, 337-340
48. Dunger, D. B., and Leonard, J. V. (1982) Value of the glucagon test in screening for hepatic glycogen storage disease. Arch. Dis. Child. 57, 384-389
49. Burwinkel, B., Rootwelt, T., Kvittingen, E. A., Chakraborty, P. K., and Kilimann, M. W. (2003) Severe phenotype of phosphorylase kinase-deficient liver glycogenosis with mutations in the PHKG2 gene. Pediatr. Res. 54, 834-839
50. Oei, T. L. (1962) Hexose monophosphate, pyruvate and lactate in the peripheral blood in glycogen-storage disease type I. Clin Chim. Acta 7, 193-198
51. Haworth, J. C., Robinson, B. H., and Perry, T. L. (1981) Lactic acidosis due to pyruvate carboxylase deficiency. J. Inherit. Metab. Dis. 4, 57-58
52. Milan, D., Jeon, J. T., Looft, C., Amarger, V., Robic, A., Thelander, M., Rogel-Gaillard, C., Paul, S., Iannuccelli, N., Rask, L., Ronne, H., Lundström, K., Reinsch, N., Gellin, J., Kalm, E., Roy, P. L., Chardon, P., and Andersson, L. (2000) A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle. Science 288, 1248-1251
53. Ota, S., Horigome, K., Ishii, T., Nakai, M., Hayashi, K., Kawamura, T., Kishino, A., Taiji, M., and Kimura, T. (2009) Metformin suppresses glucose- 6-phosphatase expression by a complex I inhibition and AMPK activation-independent mechanism. Biochem. Biophys. Res. Commun. 388, 311-316
54. Hsu, F. L., Huang, C. F., Chen, Y. W., Yen, Y. P., Wu, C. T., Uang, B. J., Yang, R. S., and Liu, S. H. (2013) Antidiabetic effects of pterosin A, a small-molecular-weight natural product, on diabetic mouse models. Diabetes 62, 628-638